Document:

SHARE

    EXCHANGE
AGREEMENT

    

    by
and among

    

    American
Antiquities, Inc.

    an
Illinois corporation

    

    and

    

    Pet
Airways, Inc.

    a Florida
Corporation

    

    and

    

    the Shareholders of

    Pet
Airways, Inc.

    

    and

    

    

    Joseph A.
Merkel, Kevin T. Quinlan, and
Bellevue Holdings, Inc., the Majority Shareholders
of

     American
Antiquities, Inc.

    

    

    

    

    Dated as
of June 25, 2010

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    SHARE
EXCHANGE AGREEMENT

     

    THIS SHARE  EXCHANGE
AGREEMENT (hereinafter referred to as this “Agreement”) is
entered into as of this __ day of June, 2010, by and between American
Antiquities, Inc., an Illinois corporation (hereinafter referred to as “AAQS”) and Joseph A.
Merkel, Kevin T. Quinlan, and Bellevue Holdings, Inc., together, the majority
Shareholders of AAQS (the “AAQS Shareholders”),
Pet Airways, Inc., a Florida corporation (formerly Panther Air Cargo LLC and
hereinafter referred to as “PAWS”), and the
shareholders of PAWS (the “PAWS  Shareholders”),
upon the following premises:

    

    Premises

     

    WHEREAS, AAQS is a publicly
traded corporation quoted on the Over-The-Counter Bulletin Board (the
“OTCBB”);

     

    WHEREAS, AAQS agrees to
acquire up to 100% of the issued and outstanding shares of PAWS from the PAWS
Shareholders in exchange for the issuance of certain shares of AAQS (the “Exchange”) and the
PAWS Shareholders agree to exchange their shares of PAWS on the terms described
herein. On the Closing Date (as defined in Section 4.05), PAWS will become a
wholly-owned subsidiary of AAQS;

     

    WHEREAS, the boards of
directors of AAQS and PAWS have determined, subject to the terms and conditions
set forth in this Agreement, that the transaction contemplated hereby is
desirable and in the best interests of their stockholders,
respectively.  This Agreement is being entered into for the purpose of
setting forth the terms and conditions of the proposed acquisition.

     

    Agreement

     

    NOW THEREFORE, on the stated
premises and for and in consideration of the mutual covenants and agreements
hereinafter set forth and the mutual benefits to the parties to be derived, and
intending to be legally bound hereby, it is hereby agreed as
follows:

     

    

    ARTICLE I

    REPRESENTATIONS,
COVENANTS, AND WARRANTIES OF PAWS

     

    As an
inducement to, and to obtain the reliance of AAQS, except as set forth in the
PAWS Schedules (as hereinafter defined), PAWS represents and warrants as of the
Closing Date, as defined below, as follows:

     

    Section
1.01           Incorporation.
 PAWS is a
company duly incorporated, validly existing, and in good standing under the laws
of the State of Florida and has the corporate power and is duly authorized under
all applicable laws, regulations, ordinances, and orders of public authorities
to carry on its business in all material respects as it is now being
conducted.  Included in the PAWS Schedules is a complete and correct
copy of the articles of incorporation (“Charter”) of PAWS as
in effect on the date hereof.  The execution and delivery of this
Agreement does not, and the consummation of the transactions contemplated hereby
will not, violate any provision of PAWS’ Charter.  PAWS has taken all
actions required by law, its Charter, or otherwise to authorize the execution
and delivery of this Agreement.  PAWS has full power, authority, and
legal capacity and has taken all action required by law, its Charter, and
otherwise to consummate the transactions herein contemplated.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    Section
1.02           Authorized
Shares.  The
number of shares which PAWS is authorized to issue consists of 15,000,000 shares
of common stock, par value of $0.01 per share.  There are 11,534,575
shares currently issued and outstanding.  The issued and outstanding
shares are validly issued, fully paid, and non-assessable and not issued in
violation of the preemptive or other rights of any person.

     

    Section
1.03           Subsidiaries and Predecessor
Corporations.  Except
as set forth in the PAWS  Schedule 1.03, PAWS
does not have any subsidiaries, and does not own, beneficially or of record, any
shares of or control any other corporation.  For purposes hereinafter,
the term “PAWS” also includes those subsidiaries set forth on the PAWS
Schedules.

     

    Section
1.04           Financial
Statements.

     

    (a)           Included
in the PAWS Schedule
1.04 are (i) the audited balance sheets of PAWS as of December 31, 2008
and 2009 and the related audited statements of operations, stockholders’ equity
and cash flows for the fiscal years ended December 31, 2008 and 2009 together
with the notes to such statements and the opinion of KBL, LLP, independent
certified public accountants. All such financial statements have been prepared
in accordance with generally accepted accounting principles consistently applied
throughout the periods involved. The PAWS balance sheets are true and accurate
and present fairly as of their respective dates the financial condition of
PAWS.  As of the date of such balance sheets, except as and to the
extent reflected or reserved against therein, PAWS had no liabilities or
obligations (absolute or contingent) which should be reflected in the balance
sheets or the notes thereto prepared in accordance with generally accepted
accounting principles, and all assets reflected therein are properly reported
and present fairly the value of the assets of PAWS, in accordance with generally
accepted accounting principles. The statements of operations, stockholders’
equity and cash flows reflect fairly the information required to be set forth
therein by generally accepted accounting principles.

     

    (b)           PAWS
has duly and punctually paid all governmental fees and taxation which it has
become liable to pay and has duly allowed for all taxation reasonably
foreseeable and is under no liability to pay any penalty or interest in
connection with any claim for governmental fees or taxation and PAWS has made
any and all proper declarations and returns for taxation purposes and all
information contained in such declarations and returns is true and complete and
full provision or reserves have been made in its financial statements for all
governmental fees and taxation.

     

    (c)           The
books and records, financial and otherwise, of PAWS are in all material aspects
complete and correct and have been maintained in accordance with generally
accepted accounting principles consistently applied throughout the periods
involved.

     

    (d)           All
of PAWS’ assets are reflected on its financial statements, and, except as set
forth in the PAWS Schedules or the financial statements of PAWS or the notes
thereto, PAWS has no material liabilities, direct or indirect, matured or
unmatured, contingent or otherwise.

     

    Section
1.05           Information.  The
information concerning PAWS set forth in this Agreement and in the PAWS
Schedules is complete and accurate in all material respects and does not contain
any untrue statement of a material fact or omit to state a material fact
required to make the statements made, in light of the circumstances under which
they were made, not misleading.  In addition, PAWS has fully disclosed
in writing to AAQS (through this Agreement or the PAWS Schedules) all
information relating to matters involving PAWS or its assets or its present or
past operations or activities which (i) indicated or may indicate, in the
aggregate, the existence of a greater than $500,000 liability, (ii) have led or
may lead to a competitive disadvantage on the part of PAWS or (iii) either alone
or in aggregation with other information covered by this Section, otherwise have
led or may lead to a material adverse effect on PAWS, its assets, or its
operations or activities as presently conducted or as contemplated to be
conducted after the Closing Date, including, but not limited to, information
relating to governmental, employee, environmental, litigation and securities
matters and transactions with affiliates.

    

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    Section
1.06           Options or
Warrants.  Except
as set forth in the PAWS Schedule 1.06, there
are no existing options, warrants, calls, or commitments of any character
relating to the authorized and unissued stock of PAWS.

     

    Section
1.07           Absence of Certain Changes
or Events.  Since
September 30, 2009:

     

    (a)           There
has not been any material adverse change in the business, operations,
properties, assets, or condition (financial or otherwise) of PAWS;

     

    (b)           PAWS
has not (i) amended its memorandum of association or articles of association;
(ii) declared or made, or agreed to declare or make, any payment of dividends or
distributions of any assets of any kind whatsoever to stockholders or purchased
or redeemed, or agreed to purchase or redeem, any of its shares; (iii) made any
material change in its method of management, operation or accounting, (iv)
entered into any other material transaction other than sales in the ordinary
course of its business; or (v) made any increase in or adoption of any profit
sharing, bonus, deferred compensation, insurance, pension, retirement, or other
employee benefit plan, payment, or arrangement made to, for, or with its
officers, directors, or employees; and

     

    (c)           PAWS
has not (i) granted or agreed to grant any options, warrants or other rights for
its stocks, bonds or other corporate securities calling for the issuance
thereof, (ii) borrowed or agreed to borrow any funds or incurred, or become
subject to, any material obligation or liability (absolute or contingent) except
as disclosed herein and except liabilities incurred in the ordinary course of
business; (iii) sold or transferred, or agreed to sell or transfer, any of its
assets, properties, or rights or canceled, or agreed to cancel, any debts or
claims; or (iv) issued, delivered, or agreed to issue or deliver any stock,
bonds or other corporate securities including debentures (whether authorized and
unissued or held as treasury stock) except in connection with this
Agreement.

     

    Section 1.08           Litigation and
Proceedings. Except
as disclosed on Schedule 1.08, there
are no actions, suits, proceedings, or investigations pending or, to the
knowledge of PAWS after reasonable investigation, threatened by or against PAWS
or affecting PAWS or its properties, at law or in equity, before any court or
other governmental agency or instrumentality, domestic or foreign, or before any
arbitrator of any kind.  PAWS does not have any knowledge of any
material default on its part with respect to any judgment, order, injunction,
decree, award, rule, or regulation of any court, arbitrator, or governmental
agency or instrumentality or of any circumstances which, after reasonable
investigation, would result in the discovery of such a default.

     

    Section
1.09           Contracts.

     

    (a)           All
“material” contracts, agreements, franchises, license agreements, debt
instruments or other commitments to which  PAWS is a party or by which
it or any of its assets, products, technology, or properties are bound other
than those incurred in the ordinary course of business are set forth on the PAWS
Schedules.  A “material” contract, agreement, franchise, license
agreement, debt instrument or commitment is one which (i) will remain in effect
for more than six (6) months after the date of this Agreement or (ii) involves
aggregate obligations of at least five thousand dollars ($5,000);

     

    (b)           All
contracts, agreements, franchises, license agreements, and other commitments to
which PAWS is a party or by which its properties are bound and which are
material to the operations of PAWS taken as a whole are valid and enforceable by
PAWS in all respects, except as limited by bankruptcy and insolvency laws and by
other laws affecting the rights of creditors generally; and

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    (c)           Except as
included or described in the PAWS Schedule 1.09 or
reflected in the most recent PAWS balance sheet, PAWS is not a party to any oral
or written (i) contract for the employment of any officer or employee; (ii)
profit sharing, bonus, deferred compensation, stock option, severance pay,
pension benefit or retirement plan, (iii) agreement, contract, or indenture
relating to the borrowing of money, (iv) guaranty of any obligation; (vi)
collective bargaining agreement; or (vii) agreement with any present or former
officer or director of PAWS.

     

    Section
1.10           No Conflict With Other
Instruments.  The
execution of this Agreement and the consummation of the transactions
contemplated by this Agreement will not result in the breach of any term or
provision of, constitute a default under, or terminate, accelerate or modify the
terms of any indenture, mortgage, deed of trust, or other material agreement, or
instrument to which PAWS is a party or to which any of its assets, properties or
operations are subject.

     

    Section
1.11           Compliance With Laws and
Regulations.  To the
best of its knowledge, PAWS has complied with all applicable statutes and
regulations of any federal, state, or other governmental entity or agency
thereof, except to the extent that noncompliance would not materially and
adversely affect the business, operations, properties, assets, or condition of
PAWS or except to the extent that noncompliance would not result in the
occurrence of any material liability for PAWS.  This compliance
includes, but is not limited to, the filing of all reports to date with federal
and state securities authorities.

     

    Section
1.12           Approval of
Agreement.  The
Board of Directors of PAWS has authorized the execution and delivery of this
Agreement by PAWS and has approved this Agreement and the transactions
contemplated hereby, and will recommend to the PAWS Shareholders that the
Exchange be accepted.

     

    Section
1.13           PAWS
Schedules.  PAWS
has delivered to AAQS the following schedules, which are collectively referred
to as the “PAWS Schedules” and which consist of separate schedules dated as of
the date of execution of this Agreement, all certified by the chief executive
officer of PAWS as complete, true, and correct as of the date of this Agreement
in all material respects:

     

    (a)           a
schedule containing a complete and correct copy of the Charter of PAWS in effect
as of the date of this Agreement;

     

    (b)           a
schedule containing the financial statements of PAWS identified in paragraph
1.04(a);

     

    (c)           a
schedule setting forth a description of any material adverse change in the
business, operations, property, inventory, assets, or condition of PAWS since
September 30, 2009, required to be provided pursuant to Section 1.07
hereof;

     

    (d)           a
schedule of any exceptions to the representations made herein; and

     

    (e)           a
schedule containing the other information requested above.

     

    PAWS
shall cause the PAWS Schedules and the instruments and data delivered to AAQS
hereunder to be promptly updated after the date hereof up to and including the
Closing Date.

     

    Section
1.14           Valid
Obligation.  This
Agreement and all agreements and other documents executed by PAWS in connection
herewith constitute the valid and binding obligation of PAWS, enforceable in
accordance with its or their terms, except as may be limited by bankruptcy,
insolvency, moratorium or other similar laws affecting the enforcement of
creditors’ rights generally and subject to the qualification that the
availability of equitable remedies is subject to the discretion of the court
before which any proceeding therefore may be brought.

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    

    ARTICLE II

    REPRESENTATIONS,
COVENANTS, AND WARRANTIES OF BELLEVUE
HOLDINGS, INC.

     

    As an
inducement to, and to obtain the reliance of PAWS and the PAWS Shareholders,
except as set forth in the AAQS Schedules (as hereinafter defined), Bellevue Holdings, Inc. (“BHI”) represents and warrants, as
of the date hereof and as of the Closing Date, as follows:

     

    Section
2.01           Organization.  AAQS
is a corporation duly incorporated, validly existing, and in good standing under
the laws of Illinois and has the corporate power and is duly authorized under
all applicable laws, regulations, ordinances, and orders of public authorities
to carry on its business in all material respects as it is now being
conducted.  Included in the AAQS Schedules are complete and correct
copies of the certificate of incorporation and bylaws of AAQS (the “Articles”) as in
effect on the date hereof. The execution and delivery of this Agreement does
not, and the consummation of the transactions contemplated hereby will not,
violate any provision of AAQS’ certificate of incorporation or
Articles.  AAQS has taken all action required by law, its certificate
of incorporation, its Articles, or otherwise to authorize the execution and
delivery of this Agreement, and AAQS has full power, authority, and legal right
and has taken all action required by law, its certificate of incorporation,
Articles, or otherwise to consummate the transactions herein
contemplated.

     

    Section
2.02            Capitalization.

    

    (a)       AAQS’
authorized capitalization consists of (a) 100,000,000 shares of common stock,
par value $0.001 per share, of which 15,980,500 shares
are issued and outstanding, and (b) 10,000,000 shares of preferred shares, par
value $0.001 per share, of which no shares of preferred stock are issued and
outstanding.  All issued and outstanding shares are legally issued,
fully paid, and non-assessable and not issued in violation of the preemptive or
other rights of any person. As of the Closing Date, (i) no shares of AAQS’
common stock were reserved for issuance upon the exercise of outstanding options
to purchase the common shares; (ii) no common shares were reserved for issuance
upon the exercise of outstanding warrants to purchase AAQS common shares; (iii)
no shares of preferred stock were reserved for issuance to any party; and (iv)
no common shares were reserved for issuance upon the conversion of AAQS
preferred stock or any outstanding convertible notes, debentures or
securities.  All outstanding AAQS common shares have been issued and
granted in compliance with (i) all applicable securities laws and (in all
material respects) other applicable laws and regulations, and (ii) all
requirements set forth in any applicable Contracts.

    

    (b)           There
are no equity securities, partnership interests or similar ownership interests
of any class of any equity security of AAQS, or any securities exchangeable or
convertible into or exercisable for such equity securities, partnership
interests or similar ownership interests, issued, reserved for issuance or
outstanding.   Except as contemplated by this Agreement, there
are no subscriptions, options, warrants, equity securities, partnership
interests or similar ownership interests, calls, rights (including preemptive
rights), commitments or agreements of any character to which AAQS is a party or
by which it is bound obligating AAQS to issue, deliver or sell, or cause to be
issued, delivered or sold, or repurchase, redeem or otherwise acquire, or cause
the repurchase, redemption or acquisition of, any shares of capital stock,
partnership interests or similar ownership interests of AAQS or obligating AAQS
to grant, extend, accelerate the vesting of or enter into any such subscription,
option, warrant, equity security, call, right, commitment or
agreement.  There is no plan or arrangement to issue AAQS common
shares or preferred stock except as set forth in this Agreement.

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    Except as
contemplated by this Agreement, there are no registration rights, and there is
no voting trust, proxy, rights plan, anti-takeover plan or other agreement or
understanding to which AAQS is a party or by which it is bound with respect to
any equity security of any class of AAQS, and there are no agreements to which
AAQS is a party, or which AAQS has knowledge of, which conflict with this
Agreement or the transactions contemplated herein or otherwise prohibit the
consummation of the transactions contemplated hereunder.

    

    Section
2.03           Subsidiaries and Predecessor
Corporations. AAQS
does not have any predecessor corporation(s), no subsidiaries, and does not own,
beneficially or of record, any shares of any other corporation.

     

    Section
2.04            Financial
Statements.

     

    (a)           Included in the AAQS Schedules are (i)
the audited balance sheets of AAQS as of October 31, 2008 and 2009 and the
related audited statements of operations, stockholders’ equity and cash flows
for October 31, 2008 and 2009, together with the notes to such statements and
the opinion of Cordovano and Honeck LLP, independent certified public
accountants, with respect thereto;

     

    (b)           All
such financial statements have been prepared in accordance with generally
accepted accounting principles consistently applied throughout the periods
involved. The AAQS balance sheets are true and accurate and present fairly as of
their respective dates the financial condition of AAQS.  As of the
date of such balance sheets, except as and to the extent reflected or reserved
against therein, AAQS had no liabilities or obligations (absolute or contingent)
which should be reflected in the balance sheets or the notes thereto prepared in
accordance with generally accepted accounting principles, and all assets
reflected therein are properly reported and present fairly the value of the
assets of AAQS, in accordance with generally accepted accounting principles. The
statements of operations, stockholders’ equity and cash flows reflect fairly the
information required to be set forth therein by generally accepted accounting
principles;

     

    (d)           AAQS
has no liabilities with respect to the payment of any federal, state, county,
local or other taxes (including any deficiencies, interest or penalties), except
for taxes accrued but not yet due and payable;

     

    (e)           AAQS
has timely filed all state, federal or local income and/or franchise tax returns
required to be filed by it from inception to the date hereof.  Each of
such income tax returns reflects the taxes due for the period covered thereby,
except for amounts which, in the aggregate, are immaterial;

     

    (f)           The
books and records, financial and otherwise, of AAQS are in all material aspects
complete and correct and have been maintained in accordance with generally
accepted accounting principles consistently applied throughout the periods
involved; and

     

    (g)           All
of AAQS’ assets are reflected on its financial statements, and, except as set
forth in the AAQS Schedules or the financial statements of AAQS or the notes
thereto, AAQS has no material liabilities, direct or indirect, matured or
unmatured, contingent or otherwise.

     

    Section
2.05           Information.  The
information concerning AAQS set forth in this Agreement and the AAQS Schedules
is complete and accurate in all material respects and does not contain any
untrue statements of a material fact or omit to state a material fact required
to make the statements made, in light of the circumstances under which they were
made, not misleading.  In addition, AAQS has fully disclosed in
writing to PAWS (through this Agreement or the AAQS Schedules) all information
relating to matters involving AAQS or its assets or its present or past
operations or activities which (i) indicated or may indicate, in the aggregate,
the existence of a greater than $1,000 liability, (ii) have led or may lead to a
competitive disadvantage on the part of AAQS or (iii) either alone or in
aggregation with other information covered by this Section, otherwise have led
or may lead to a material adverse effect on AAQS, its assets, or its operations
or activities as presently conducted or as contemplated to be conducted after
the Closing Date, including, but not limited to, information relating to
governmental, employee, environmental, litigation and securities matters and
transactions with affiliates.

    

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    Section
2.06           Options or
Warrants.  There
are no existing options, warrants, calls, or commitments of any character
relating to the authorized and unissued stock of AAQS.

     

    Section 2.07           Absence of Certain Changes
or Events.  Since
the date of the most recent AAQS balance sheet:

     

    (a)           there
has not been (i) any material adverse change in the business, operations,
properties, assets or condition of AAQS or (ii) any damage, destruction or loss
to AAQS (whether or not covered by insurance) materially and adversely affecting
the business, operations, properties, assets or condition of AAQS;

     

    (b)           AAQS
has not (i) amended its certificate of incorporation or Articles except as
required by this Agreement; (ii) declared or made, or agreed to declare or make
any payment of dividends or distributions of any assets of any kind whatsoever
to stockholders or purchased or redeemed, or agreed to purchase or redeem, any
of its capital stock; (iii) waived any rights of value which in the aggregate
are outside of the ordinary course of business or material considering the
business of AAQS; (iv) made any material change in its method of management,
operation, or accounting; (v) entered into any transactions or agreements other
than in the ordinary course of business; (vi) made any accrual or arrangement
for or payment of bonuses or special compensation of any kind or any severance
or  termination pay to any present or former officer or employee;
(vii) increased the rate of compensation payable or to become payable by it to
any of its officers or directors or any of its salaried employees whose monthly
compensation exceed $1,000; or  (viii) made any increase in any profit
sharing, bonus, deferred compensation, insurance, pension, retirement, or other
employee benefit plan, payment, or arrangement, made to, for or with its
officers, directors, or employees;

     

    (c)           AAQS
has not (i) granted or agreed to grant any options, warrants, or other rights
for its stock, bonds, or other corporate securities calling for the issuance
thereof; (ii) borrowed or agreed to borrow any funds or incurred, or become
subject to, any material obligation or liability (absolute or contingent) except
liabilities incurred in the ordinary course of business; (iii) paid or agreed to
pay any material obligations or liabilities (absolute or contingent) other than
current liabilities reflected in or shown on the most recent AAQS balance sheet
and current liabilities incurred since that date in the ordinary course of
business and professional and other fees and expenses in connection with the
preparation of this Agreement and the consummation of the transaction
contemplated hereby; (iv) sold or transferred, or agreed to sell or transfer,
any of its assets, properties, or rights (except assets, properties, or rights
not used or useful in its business which, in the aggregate have a value of less
than $1,000), or canceled, or agreed to cancel, any debts or claims (except
debts or claims which in the aggregate are of a value less than $1,000); (v)
made or permitted any amendment or termination of any contract, agreement, or
license to which it is a party if such amendment or termination is material,
considering the business of AAQS; or (vi) issued, delivered or agreed to issue
or deliver, any stock, bonds or other corporate securities including debentures
(whether authorized and unissued or held as treasury stock), except in
connection with this Agreement; and

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

     

    (d)           To BHI’s
knowledge, AAQS has not become subject to any law or regulation which materially
and adversely affects, or in the future, may adversely affect, the business,
operations, properties, assets or condition of AAQS.

     

    Section
2.08           Litigation and
Proceedings.  There
are no actions, suits, proceedings or investigations pending or, to the
knowledge of BHI after reasonable investigation, threatened by or against AAQS
or affecting AAQS or its properties, at law or in equity, before any court or
other governmental agency or instrumentality, domestic or foreign, or before any
arbitrator of any kind.  BHI has no knowledge of any default on its
part with respect to any judgment, order, writ, injunction, decree, award, rule
or regulation of any court, arbitrator, or governmental agency or
instrumentality or any circumstance which after reasonable investigation would
result in the discovery of such default.

     

    Section
2.09           Contracts.

     

    (a)           AAQS
is not a party to, and its assets, products, technology and properties are not
bound by, any contract, franchise, license agreement, agreement, debt instrument
or other commitments whether such agreement is in writing or oral;

     

    (b)           AAQS
is not a party to or bound by, and the properties of AAQS are not subject to any
contract, agreement, other commitment or instrument; any charter or other
corporate restriction; or any judgment, order, writ, injunction, decree, or
award; and

     

    (c)           Except
for employment agreements to be mutually terminated at, or prior to the Closing
Date by AAQS and the employees party thereto, AAQS is not a party to any oral or
written (i) contract for the employment of any officer or employee; (ii) profit
sharing, bonus, deferred compensation, stock option, severance pay, pension
benefit or retirement plan, (iii) agreement, contract, or indenture relating to
the borrowing of money, (iv) guaranty of any obligation, (vi) collective
bargaining agreement; or (vii) agreement with any present or former officer or
director of AAQS.

     

    Section
2.10           No Conflict With Other
Instruments.  The
execution of this Agreement and the consummation of the transactions
contemplated by this Agreement will not result in the breach of any term or
provision of, constitute a default under, or terminate, accelerate or modify the
terms of, any indenture, mortgage, deed of trust, or other material agreement or
instrument to which AAQS is a party or to which any of its assets, properties or
operations are subject.

     

    Section
2.11           Compliance With Laws and
Regulations.  To the
best of BHI’s knowledge, AAQS has complied with all applicable statutes and
regulations of any federal, state, or other applicable governmental entity or
agency thereof.  This compliance includes, but is not limited to, the
filing of all reports to date with federal and state securities
authorities.

     

    Section
2.12           Approval of
Agreement.  The
Board of Directors of AAQS has authorized the execution and delivery of this
Agreement by AAQS and has approved this Agreement and the transactions
contemplated hereby.

     

    Section
2.13           Material Transactions or
Affiliations.  Except
as disclosed herein and in the AAQS Schedules, there exists no contract,
agreement or arrangement between AAQS and any predecessor and any person who was
at the time of such contract, agreement or arrangement an officer, director, or
person owning of record or known by AAQS to own beneficially, 5% or more of the
issued and outstanding common shares of AAQS and which is to be performed in
whole or in part after the date hereof or was entered into not more than three
years prior to the date hereof.  Neither any officer, director, nor 5%
Shareholders of AAQS has, or has had since inception of AAQS, any known
interest, direct or indirect, in any such transaction with AAQS which was
material to the business of AAQS.  AAQS has no commitment, whether
written or oral, to lend any funds to, borrow any money from, or enter into any
other transaction with, any such affiliated person.

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

    Section
2.14           AAQS
Schedules. AAQS
has delivered, or prior to the Closing Date shall deliver, to PAWS the following
schedules, which are collectively referred to as the “AAQS Schedules” and which
consist of separate schedules, which are dated the date of this Agreement, all
certified by the chief executive officer of AAQS to be complete, true, and
accurate in all material respects as of the date of this Agreement.

     

    (a)           a
schedule containing a complete and accurate copy of the Articles of AAQS as in
effect as of the date of this Agreement;

     

    (b)           a
schedule containing the financial statements of AAQS identified in paragraph
2.04(a) and (b);

     

    (c)           a
schedule setting forth a description of any material adverse change in the
business, operations, property, inventory, assets, or condition of AAQS since
October 31, 2009, required to be provided pursuant to section 2.07 hereof;
and

     

    (d)           a
schedule setting forth any other information, together with any required copies
of documents, required to be disclosed in the AAQS Schedules by Sections 2.01
through 2.13.

     

    AAQS
shall cause the AAQS Schedules and the instruments and data delivered to PAWS
hereunder to be promptly updated after the date hereof up to and including the
Closing Date.

     

    Section
2.15           Bank Accounts; Power of
Attorney.  Set
forth in the AAQS Schedules is a true and complete list of (a) all accounts with
banks, money market mutual funds or securities or other financial institutions
maintained by AAQS within the past twelve (12) months, the account numbers
thereof, and all persons authorized to sign or act on behalf of AAQS, (b) all
safe deposit boxes and other similar custodial arrangements maintained by AAQS
within the past twelve (12) months, (c) the check ledger for the last 12 months,
and (d) the names of all persons holding powers of attorney from AAQS or who are
otherwise authorized to act on behalf of AAQS with respect to any matter, other
than its officers and directors, and a summary of the terms of such powers or
authorizations.

     

    Section
2.16           Valid
Obligation.  This
Agreement and all agreements and other documents executed by AAQS in connection
herewith constitute the valid and binding obligation of AAQS, enforceable in
accordance with its or their terms, except as may be limited by bankruptcy,
insolvency, moratorium or other similar laws affecting the enforcement of
creditors’ rights generally and subject to the qualification that the
availability of equitable remedies is subject to the discretion of the court
before which any proceeding therefore may be brought.

     

    Section
2.17           SEC
Filings; Financial
Statements. 

     

    (a) AAQS has made available to
PAWS a correct and complete copy, or there has been available on EDGAR, copies
of each report, registration statement and definitive proxy statement filed by
AAQS with the SEC for the 36 months prior to the date of this Agreement (the
“AAQS SEC
Reports”), which, to BHI’s knowledge, are all the forms, reports and
documents filed by AAQS with the SEC for the 36 months or applicable period
prior to the date of this Agreement. As of their respective dates, to BHI’s
knowledge, the AAQS SEC Reports: (i) were prepared in accordance and complied in
all material respects with the requirements of the Securities Act or the
Exchange Act, as the case may be, and the rules and regulations of the SEC
thereunder applicable to such AAQS SEC Reports, and (ii) did not at the time
they were filed (and if amended or superseded by a filing prior to the date of
this Agreement then on the date of such filing and as so amended or superseded)
contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading.

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    (b) Each set of financial
statements (including, in each case, any related notes thereto) contained in the
AAQS SEC Reports comply as to form in all material respects with the published
rules and regulations of the SEC with respect thereto, were prepared in
accordance with U.S. GAAP applied on a consistent basis throughout the periods
involved (except as may be indicated in the notes thereto) and each fairly
presents in all material respects the financial position of AAQS at the
respective dates thereof and the results of its operations and cash flows for
the periods indicated, except that the unaudited interim financial statements
were or are subject to normal adjustments which were not or are not expected to
have a  material adverse effect upon the business, prospects,
management, properties, operations, condition (financial or otherwise) or
results of operations of AAQS, taken as a whole (“Material Adverse
Effect”).

     

    Section
2.18           Exchange Act
Compliance.  AAQS is
in compliance with, and current in, all of the reporting, filing and other
requirements under the Exchange Act, the common shares have been registered
under Section 12(g) of the Exchange Act, and AAQS is in compliance with all of
the requirements under, and imposed by, Section 12(g) of the Exchange Act,
except where a failure to so comply is not reasonably likely to have a Material
Adverse Effect on AAQS.

     

    Section
2.19           Title to Property.
AAQS does not own or lease any real property or personal
property.  There are no options or other contracts under which AAQS
has a right or obligation to acquire or lease any interest in real property or
personal property.

     

    Section
2.20           Intellectual
Property.  AAQS does not own, license or otherwise have any
right, title or interest in any intellectual property.

    

    ARTICLE III

    REPRESENTATIONS
AND WARRANTIES OF

    THE
PAWS SHAREHOLDERS

     

    The PAWS Shareholders hereby represent
and warrant, severally and solely, to AAQS as follows.

    

    Section
3.01           Good
Title.  Each of t

     

    Section
3.02           he
PAWS Shareholders is the record and beneficial owner, and has good title to his
PAWS common shares, with the right and authority to sell and deliver such PAWS
common shares, free and clear of all liens, claims, charges, encumbrances,
pledges, mortgages, security interests, options, rights to acquire, proxies,
voting trusts or similar agreements, restrictions on transfer or adverse claims
of any nature whatsoever.  Upon delivery of any certificate or
certificates duly assigned, representing the same as herein contemplated and/or
upon registering of AAQS as the new owner of such PAWS common shares in the
share register of PAWS, AAQS will receive good title to such PAWS common shares,
free and clear of all liens.

     

    Section
3.02           Power and Authority.
Each of the PAWS Shareholders has the legal power, capacity and authority to
execute and deliver this Agreement to consummate the transactions contemplated
by this Agreement, and to perform his obligations under this
Agreement.  This Agreement constitutes a legal, valid and binding
obligation of the PAWS Shareholders, enforceable against the PAWS Shareholders
in accordance with the terms hereof.

     

    Section
3.03           No
Conflicts.  The execution and delivery of this Agreement by the
PAWS Shareholders and the performance by the PAWS Shareholders of their
obligations hereunder in accordance with the terms hereof: (a) will not require
the consent of any third party or governmental entity under any laws; (b) will
not violate any laws applicable to the PAWS Shareholders and (c) will not
violate or breach any contractual obligation to which the PAWS Shareholders are
a party. 

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

     

    Section
3.04           Finder’s
Fee.  Each of the PAWS Shareholders represents and warrants
that it has not created any obligation for any finder’s, investment banker’s or
broker’s fee in connection with the Exchange.

    

    Section
3.05           Purchase Entirely for Own
Account. The Exchange Shares (as defined in Section 4.01 herein) proposed
to be acquired by each of the PAWS Shareholders hereunder will be acquired for
investment for its own account, and not with a view to the resale or
distribution of any part thereof, and each of the PAWS Shareholders has no
present intention of selling or otherwise distributing the Exchange Shares,
except in compliance with applicable securities laws.

    

    Section
3.06           Acquisition of Exchange
Shares for Investment.

    

    (a)           Each
PAWS Shareholder is acquiring the Exchange Shares for investment for PAWS
Shareholder’s own account and not as a nominee or agent, and not with a view to
the resale or distribution of any part thereof, and each PAWS Shareholder has no
present intention of selling, granting any participation in, or otherwise
distributing the same.  Each PAWS Shareholder further represents that
he or she does not have any contract, undertaking, agreement or arrangement with
any person to sell, transfer or grant participation to such person or to any
third person, with respect to any of the Exchange Shares.

     

    (b)           Each
PAWS Shareholder represents and warrants that he or she: (i) can bear the
economic risk of his respective investments, and (ii) possesses such knowledge
and experience in financial and business matters that he is capable of
evaluating the merits and risks of the investment in AAQS and its
securities.

     

    (c)           Each
PAWS Shareholder understands that the Exchange Shares are not registered under
the Securities Act and that the issuance thereof to such PAWS Shareholder is
intended to be exempt from registration under the Securities Act pursuant to
Regulation D promulgated thereunder (“Regulation
D”).  Each PAWS Shareholder represents and warrants that he or
she is an “accredited investor” as such term is defined in Rule 501 of
Regulation D or, if not an accredited investor, that such PAWS Shareholder
otherwise meets the suitability requirements of Regulation D and Section 4(2) of
the Securities Act (“Section 4(2)”). Each PAWS Shareholder
agrees to provide documentation to AAQS prior to Closing as may be requested by
AAQS to confirm compliance with Regulation D and/or Section 4(2), including,
without limitation, a letter of investment intent or similar representation
letter and a completed investor questionnaire. Each certificate
representing the Exchange Shares issued to such PAWS Shareholder shall be
endorsed with the following legends, in addition to any other legend required to
be placed thereon by applicable federal or state securities laws:

     

    “THIS
SECURITY HAS BEEN ACQUIRED FOR INVESTMENT AND HAS NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (“SECURITIES ACT”), OR APPLICABLE STATE
SECURITIES OR “BLUE SKY” LAWS.”

     

    “TRANSFER
OF THESE SECURITIES IS PROHIBITED UNLESS A REGISTRATION STATEMENT UNDER THE
SECURITIES ACT WITH RESPECT TO SUCH SECURITY SHALL THEN BE IN EFFECT AND SUCH
TRANSFER HAS BEEN QUALIFIED UNDER ALL APPLICABLE STATE SECURITIES OR “BLUE SKY”
LAWS, OR AN EXEMPTION THEREFROM SHALL BE AVAILABLE UNDER THE ACT AND SUCH
LAWS.”

     

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

     

    (d)           Each PAWS
Shareholder acknowledges that neither the SEC, nor the securities regulatory
body of any state or other jurisdiction, has received, considered or passed upon
the accuracy or adequacy of the information and representations made in this
Agreement.

     

    (e)           Each
PAWS Shareholder acknowledges that he or she has carefully reviewed such
information as deemed necessary to evaluate an investment in AAQS and its
securities, and that all information required to be disclosed to such PAWS
Shareholder under Regulation D has been furnished to such PAWS Shareholder by
AAQS.  To the full satisfaction of each PAWS Shareholder, he or she
has been furnished all materials that has been requested relating to AAQS and
the issuance of the Exchange Shares hereunder, and each PAWS Shareholder has
been afforded the opportunity to ask questions of AAQS’ representatives to
obtain any information necessary to verify the accuracy of any representations
or information made or given to the PAWS
Shareholders.  Notwithstanding the foregoing, nothing herein shall
derogate from or otherwise modify the representations and warranties of AAQS set
forth in this Agreement, on which each of the PAWS Shareholders have relied in
making an exchange of his or her shares in PAWS for the Exchange
Shares.

     

    (f)           Each
PAWS Shareholder understands that the Exchange Shares may not be sold,
transferred, or otherwise disposed of without registration under the Securities
Act or an exemption therefrom, and that in the absence of an effective
registration statement covering the Exchange Shares or any available exemption
from registration under the Securities Act, the Exchange Shares may have to be
held indefinitely.  Each PAWS Shareholder further acknowledges that
the Exchange Shares may not be sold pursuant to Rule 144 promulgated under the
Securities Act unless all of the conditions of Rule 144 are satisfied
(including, without limitation, AAQS’ compliance with the reporting requirements
under the Securities Exchange Act of 1934, as amended (“Exchange
Act”)).

     

    (g)           Each
PAWS Shareholder agrees that, notwithstanding anything contained herein to the
contrary, the warranties, representations, agreements and covenants of the PAWS
Shareholder under this Section 3.06 shall survive the Closing.

     

    Section
3.07           Additional Legend;
Consent. Additionally, the Exchange Shares will bear any legend required
by the “blue sky” laws of any state to the extent such laws are applicable to
the securities represented by the certificate so legended.  Each of
the PAWS Shareholders consents to AAQS making a notation on its records or
giving instructions to any transfer agent of Exchange Shares in order to
implement the restrictions on transfer of the Exchange Shares.

    

    ARTICLE IV

    PLAN
OF EXCHANGE

     

    Section
4.01           The
Exchange.  On
the terms and subject to the conditions set forth in this Agreement, on the
Closing Date, (a) each of the PAWS Shareholders who has elected to accept the
exchange offer described herein by executing this Agreement, shall assign,
transfer and deliver, free and clear of all liens, pledges, encumbrances,
charges, restrictions or known claims of any kind, nature, or description, the
number of shares of PAWS set forth on the PAWS Schedules attached hereto,
constituting all of the shares of PAWS held by such shareholder, (b) the holder
of the PAWS 14% convertible Debenture in principal amount of $250,000 issued on
June ___, 2010 (the “PAWS 14% Debenture”) shall assign, transfer and deliver,
free and clear of all liens, pledges, encumbrances, charges, restrictions or
known claims of any kind, nature, or description, the PAWS 14% Debenture and (b)
the holders of the PAWS 8% convertible Debenture in principal amount of $900,000
(the “PAWS 8% Debenture”) shall assign, transfer and deliver, free and clear of
all liens, pledges, encumbrances, charges, restrictions or known claims of any
kind, nature, or description, the PAWS 8% Debenture; the objective of such
Exchange being the acquisition by AAQS of not less than 100% of the issued and
outstanding shares of PAWS.  In exchange for the transfer of such
securities by the PAWS Shareholders, AAQS shall issue to (a) the PAWS
Shareholders, their affiliates or assigns, a total of 25,000,000 shares of AAQS
Common Stock pursuant to Table 1 attached
hereto, representing approximately 75.8% of the total common shares of AAQS, for
all of the outstanding shares of PAWS held by the PAWS Shareholders (the “Exchange Shares”),
(b) the holder of the PAWS 14% Debenture an 8% Debenture convertible into shares
of AAQS at $.40 per share and a warrant to acquire shares of AAQS stock at $1.00
per share and (c) the holders of the PAWS 8% Debenture an 8% Debenture
convertible into shares of AAQS at $.40 per share and a warrant to acquire
shares of AAQS stock at $1.00 per share. At the Closing Date, each of the PAWS
Shareholders shall, on surrender of their certificate or certificates
representing his PAWS shares to AAQS or its registrar or transfer agent, be
entitled to receive a certificate or certificates evidencing his proportionate
interest in the Exchange Shares.

     

    
      
         

      

      
        12

        
          

        

      

      
         

      

    

    Upon
consummation of the transaction contemplated herein, all of the issued and
outstanding shares of PAWS shall be held by AAQS. Upon consummation of the
transaction contemplated herein there shall be approximately 33,000,000 AAQS
common shares issued and outstanding and no shares of Preferred Stock
outstanding.

     

    Section
4.02           Satisfaction of Present
Liabilities of AAQS.  At or prior to
the Closing Date, the liabilities and obligations of AAQS as set forth on
Schedule 4.02 shall be satisfied by AAQS.

    

    Section
4.03           Closing. The closing (the
“Closing” or
the “Closing
Date”) of the transactions contemplated by this Agreement shall occur on
________, 2010 upon the exchange of the shares of AAQS and PAWS as described in
Section 4.01 herein. Such Closing shall take place at a mutually agreeable time
and place, and be conditioned upon all of the conditions of the Offering being
met.

     

    Section
4.04           Closing
Events.  At the
Closing, AAQS, PAWS and the PAWS Shareholders shall execute, acknowledge, and
deliver (or shall ensure to be executed, acknowledged, and delivered), any and
all certificates, opinions, financial statements, schedules, agreements,
resolutions, rulings or other instruments required by this Agreement to be so
delivered at or prior to the Closing, together with such other items as may be
reasonably requested by the parties hereto and their respective legal counsel in
order to effectuate or evidence the transactions contemplated
hereby.

     

    Section
4.05           Termination.  This
Agreement may be terminated by the Board of Directors of PAWS or AAQS only in
the event that AAQS or PAWS does not meet the conditions precedent set forth in
Articles VI and VII.  If this Agreement is terminated pursuant to this
section, this Agreement shall be of no further force or effect, and no
obligation, right or liability shall arise hereunder.

     

    ARTICLE
V

    SPECIAL
COVENANTS

     

    Section
5.01           Assistance with Post-Closing
SEC Reports and Inquiries.Upon the
reasonable request of AAQS, after the Closing Date, BHI and the AAQS
Shareholders shall
use their respective reasonable best efforts to provide such information
available to it or him, including information, filings, reports, financial
statements or other circumstances of AAQS occurring, reported or filed prior to
the Closing, as may be necessary or required by AAQS for the preparation of the
reports that AAQS is required to file after Closing with the SEC to remain in
compliance and current with its reporting requirements under the Exchange Act,
or filings required to address and resolve matters as may relate to the period
prior to Closing and any SEC comments relating thereto or any SEC inquiry
thereof.

     

    
      
         

      

      
        13

        
          

        

      

      
         

      

    

    Section
5.02           Delivery of Books and
Records.  At the
Closing, AAQS shall deliver to PAWS, the originals of the corporate minute
books, books of account, contracts, records, and all other books or documents of
AAQS which is now in the possession of AAQS or its representatives.

     

    Section
5.03           Third Party Consents and
Certificates.  AAQS and
PAWS agree to cooperate with each other in order to obtain any required third
party consents to this Agreement and the transactions herein
contemplated.

     

    Section
5.04           [intentionally
omitted.]

     

    Section
5.05           Designation of
Officers.  After the Closing Date, all present officers of AAQS
shall resign from all their officer positions of AAQS and the persons as set
forth below shall be appointed as Officers of AAQS:

     

    
      
        
          
            	
                    Name

                  	
                    Position

                  
	
                    Daniel
      Wiesel

                  	
                    President
      and Chief Executive Officer

                  
	
                    Andrew
      Warner

                  	
                    Chief
      Financial Officer

                  
	 
      	 
      
	 
      	 
      
	 
      	 
      
	 
      	 
      

          

        

      

    

    

    Section
5.06           Indemnification.

     

    (a)           PAWS
hereby agrees to indemnify AAQS and each of the officers, agents and directors
of AAQS as of the date of execution of this Agreement against any loss,
liability, claim, damage, or expense (including, but not limited to, any and all
expense whatsoever reasonably incurred in investigating, preparing, or defending
against any litigation, commenced or threatened, or any claim whatsoever) (the
“Loss”), to
which it or they may become subject arising out of or based on any inaccuracy
appearing in or misrepresentations made under Article I of this
Agreement.  The indemnification provided for in this paragraph shall
survive the Closing and consummation of the transactions contemplated hereby and
termination of this Agreement for one year following the Closing.

     

    (b)           Each
of the PAWS Shareholders, severally and not jointly, agrees to indemnify AAQS
and each of the officers, agents and directors of AAQS as of the date of
execution of this Agreement against any Loss, to which it or they may become
subject arising out of or based on any inaccuracy appearing in or
misrepresentations made under Article III of this Agreement.  The
indemnification provided for in this paragraph shall survive the Closing and
consummation of the transactions contemplated hereby and termination of this
Agreement for one year following the Closing.

     

    (c)           BHI hereby agrees to indemnify PAWS and
each of the officers, agents, and directors of PAWS and the PAWS Shareholders as
of the date of execution of this Agreement against any Loss to which it or they
may become subject arising out of or based on any inaccuracy appearing in or
misrepresentation made under Article II of this Agreement.  The
indemnification provided for in this paragraph shall survive the Closing and
consummation of the transactions contemplated hereby and termination of this
Agreement for one year following the Closing.

     

    Section
5.06           The Acquisition of AAQS
Common Shares.  AAQS
and PAWS understand and agree that the consummation of this Agreement including
the issuance of the AAQS common shares to the PAWS Shareholders in exchange for
the PAWS Shares as contemplated hereby constitutes the offer and sale of
securities under the Securities Act and applicable state
statutes.  AAQS and PAWS agree that such transactions shall be
consummated in reliance on exemptions from the registration and prospectus
delivery requirements of such statutes, which depend, among other items, on the
circumstances under which such securities are acquired.

     

    
      
         

      

      
        14

        
          

        

      

      
         

      

    

     

    (a)           In
connection with the transaction contemplated by this Agreement, AAQS and PAWS
shall each file, with the assistance of the other and their respective legal
counsel, such notices, applications, reports, or other instruments as may be
deemed by them to be necessary or appropriate in an effort to document reliance
on such exemptions, and the appropriate regulatory authority in the states where
the shareholders of PAWS reside unless an exemption requiring no filing is
available in such jurisdictions, all to the extent and in the manner as may be
deemed by such parties to be appropriate.

     

    (b)           In
order to more fully document reliance on the exemptions as provided herein,
PAWS, the PAWS Shareholders, and AAQS shall execute and deliver to the other, at
or prior to the Closing, such further letters of representation, acknowledgment,
suitability, or the like as PAWS or AAQS and their respective counsel may
reasonably request in connection with reliance on exemptions from registration
under such securities laws.

     

    (c)           The
PAWS Shareholders acknowledge that the basis for relying on exemptions from
registration or qualifications are factual, depending on the conduct of the
various parties, and that no legal opinion or other assurance will be required
or given to the effect that the transactions contemplated hereby are in fact
exempt from registration or qualification.

     

    Section
5.07           Sales of Securities Under
Rule 144, If Applicable.

     

    (a)           AAQS
will use its best efforts to at all times satisfy the current public information
requirements of Rule 144 promulgated under the Securities Act so that its
shareholders can sell restricted securities that have been held for one year or
more or such other restricted period as required by Rule 144 as it is from time
to time amended.

     

    (b)           Upon
being informed in writing by any person holding restricted stock of AAQS that
such person intends to sell any shares under rule 144 promulgated under the
Securities Act (including any rule adopted in substitution or replacement
thereof), AAQS will certify in writing to such person that it is compliance with
Rule 144 current public information requirement to enable such person to sell
such person’s restricted stock under Rule 144, as may be applicable under the
circumstances.

     

    (c)           If
any certificate representing any such restricted stock is presented to AAQS’
transfer agent for registration or transfer in connection with any sales
theretofore made under Rule 144, provided such certificate is duly endorsed for
transfer by the appropriate person(s) or accompanied by a separate stock power
duly executed by the appropriate person(s) in each case with reasonable
assurances that such endorsements are genuine and effective, and is accompanied
by a legal opinion that such transfer has complied with the requirements of Rule
144, as the case may be, AAQS will promptly instruct its transfer agent to
register such transfer and to issue one or more new certificates representing
such shares to the transferee and, if appropriate under the provisions of Rule
144, as the case may be, free of any stop transfer order or restrictive
legend.

     

    Section
5.08           Payment of
Liabilities.  Recognizing
the need to extinguish all existing liabilities of AAQS prior to the Exchange,
PAWS has indicated it will not enter into this Agreement unless AAQS has
arranged for the payment and discharge of all of AAQS’ liabilities, including
all of AAQS’ accounts payable and any outstanding legal fees incurred prior to
the Closing Date.  Accordingly, AAQS has agreed to arrange for the
payment and discharge of all such liabilities.

     

    
      
         

      

      
        15

        
          

        

      

      
         

      

    

    Section
5.09           Schedules. Prior to
the Closing Date, (i) AAQS shall deliver to PAWS the AAQS Schedules and (ii)
PAWS shall deliver to AAQS the PAWS Schedules, which in each case shall be
correct and complete in all material respects.

     

    ARTICLE
VI

    CONDITIONS
PRECEDENT TO OBLIGATIONS OF AAQS

     

    The
obligations of AAQS under this Agreement are subject to the satisfaction, at or
before the Closing Date, of the following conditions:

     

    Section
6.01           Accuracy of Representations
and Performance of Covenants.  The
representations and warranties made by PAWS in this Agreement were true when
made and shall be true at the Closing Date with the same force and effect as if
such representations and warranties were made at and as of the Closing Date
(except for changes therein permitted by this Agreement).  PAWS shall
have performed or complied with all covenants and conditions required by this
Agreement to be performed or complied with by PAWS prior to or at the
Closing.  AAQS shall be furnished with a certificate, signed by a duly
authorized executive officer of PAWS and dated the Closing Date, to the
foregoing effect.

     

    Section
6.02           Consents.  All
consents, approvals, waivers or amendments pursuant to all contracts, licenses,
permits, trademarks and other intangibles in connection with the transactions
contemplated herein, or for the continued operation of PAWS after the Closing
Date on the basis as presently operated shall have been obtained.

     

    Section
6.03           Approval by PAWS
Shareholders.  The
Exchange shall have been approved by the holders of not less than fifty and one
tenths percent (50.01%) of the shares, including voting power, of PAWS, unless a
lesser number is agreed to by AAQS.

     

    Section
6.04           No Governmental
Prohibition.  No
order, statute, rule, regulation, executive order, injunction, stay, decree,
judgment or restraining order shall have been enacted, entered, promulgated or
enforced by any court or governmental or regulatory authority or instrumentality
which prohibits the consummation of the transactions contemplated
hereby.

     

    Section
6.05           Side Letters; Reliance
Letters.  At or prior to the Closing Date, all side letters
and/or reliance letters between AAQS or any stockholders thereof, on the one
hand, and any third parties, on the other hand, shall have been executed,
delivered, and performed in all respects.

    

    Section
6.06           PAWS Schedules. Prior
to the Closing Date, PAWS shall have delivered to AAQS the PAWS Schedules, such
PAWS Schedules shall be correct and complete in all material respects, and AAQS
shall be reasonably satisfied therewith.

    
 

    ARTICLE
VII

    CONDITIONS
PRECEDENT TO OBLIGATIONS OF PAWS

    AND
THE PAWS SHAREHOLDERS

    
      
         

      

      
        16

        
          

        

      

      
         

      

    

    The
obligations of PAWS and the PAWS Shareholders under this Agreement are subject
to the satisfaction, at or before the Closing Date, of the following
conditions:

     

    Section
7.01           Accuracy of Representations
and Performance of Covenants.  The
representations and warranties made by BHI and AAQS in this Agreement were true
when made and shall be true as of the Closing Date (except for changes therein
permitted by this Agreement) with the same force and effect as if such
representations and warranties were made at and as of the Closing
Date.  Additionally, AAQS shall have performed and complied with all
covenants and conditions required by this Agreement to be performed or complied
with by AAQS. PAWS shall be furnished with a certificate, signed by a duly
authorized executive officer of AAQS and dated the Closing Date, to the
foregoing effect.

     

    Section
7.02           Consents.  All
consents, approvals, waivers or amendments pursuant to all contracts, licenses,
permits, trademarks and other intangibles in connection with the transactions
contemplated herein, or for the continued operation of AAQS after the Closing
Date on the basis as presently operated shall have been obtained.

     

    Section
7.03           Approval of Stock Option
Plan.  The board of directors of AAQS shall through unanimous
written consent have (i) approved an Employee Incentive Stock Option Plan
(“Plan”) and reserved 4,000,000 shares of its common stock for issuance under
the Plan, (ii) recommended to the stockholders of AAQS to approve the Plan, and
(iii) instruct the officers of the Company to prepare and file a Schedule 14C
with the SEC regarding the approval of such Plan upon the receipt of the
requisite stockholder consents.

     

    Section
7.04           No Governmental
Prohibition.  No
order, statute, rule, regulation, executive order, injunction, stay, decree,
judgment or restraining order shall have been enacted, entered, promulgated or
enforced by any court or governmental or regulatory authority or instrumentality
which prohibits the consummation of the transactions contemplated
hereby.

     

    Section
7.05           Good Standing.  AAQS
shall have received a certificate of good standing from the Illinois Secretary
of State or other appropriate office, dated as of a date within ten days prior
to the Closing Date certifying that AAQS is in good standing as a company in the
State of Illinois and has filed all tax returns required to have been filed by
it to date and has paid all taxes reported as due thereon.

     

    Section
7.06           Existing
Liabilities.  AAQS shall be responsible for any and all
outstanding liabilities, direct or contingent, arising out of AAQS’ business
prior to Closing and shall have terminated the existing employment agreements
listed on Schedule
2.09 and paid all liabilities due thereunder.  AAQS shall have
paid all liabilities arising out of AAQS’ business prior to Closing, including,
without limitation, the indebtedness to related parties.

     

    Section
7.07           Financing.  PAWS
shall have completed and closed a financing yielding net proceeds of at least
$2,000,000.

    

    Section
7.08           AAQS Schedules. Prior
to the Closing Date, AAQS shall have delivered to PAWS the AAQS Schedules, such
AAQS Schedules shall be correct and complete in all material respects, and PAWS
shall be reasonably satisfied therewith.

    

    

    ARTICLE
VIII

    MISCELLANEOUS

     

    
      
         

      

      
        17

        
          

        

      

      
         

      

    

    Section
8.01           Brokers.  AAQS and
PAWS agree that, except as set out on Schedule 8.01 attached hereto, there were
no finders or brokers involved in bringing the parties together or who were
instrumental in the negotiation, execution or consummation of this
Agreement.  AAQS and PAWS agree to indemnify the other against any
claim by any third person other than those described above for any commission,
brokerage, or finder’s fee arising from the transactions contemplated hereby
based on any alleged agreement or understanding between the indemnifying party
and such third person, whether express or implied from the actions of the
indemnifying party.

     

    Section
8.02           Governing
Law.  This
Agreement shall be governed by, enforced, and construed under and in accordance
with the laws of the United States of America and, with respect to the matters
of state law, with the laws of the State of New York.  Venue for all
matters shall be in New York, New York, without giving effect to principles of
conflicts of law thereunder.  Each of the parties (a) irrevocably
consents and agrees that any legal or equitable action or proceedings arising
under or in connection with this Agreement shall be brought exclusively in the
federal courts of the United States. By execution and delivery of this
Agreement, each party hereto irrevocably submits to and accepts, with respect to
any such action or proceeding, generally and unconditionally, the jurisdiction
of the aforesaid court, and irrevocably waives any and all rights such party may
now or hereafter have to object to such jurisdiction.

     

    Section
8.03           Notices.  Any
notice or other communications required or permitted hereunder
shall  be in writing and shall be sufficiently given if personally
delivered to it or sent by telecopy, overnight courier or registered mail or
certified mail, postage prepaid, addressed as follows:

     

    
      	
               
      

            	
              If to PAWS,
      to:

            	
              Pet
      Airways, Inc.

              
                777 E. Atlantic Ave,
      #C2-264

                Delray Beach, FL
      33483

              

            

    

    

    

    
      	
               
      

            	
              With
      copies to (which shall not constitute
notice):

            

    

    

    
      	
               
      

            	
              Mark
      Crone, Esq.

            

    

    
      	
               
      

            	
              The
      Crone Law Group

            

    

    
      	
               
      

            	
              101
      Montgomery, Suite 1950

            

    

    
      	
               
      

            	
              San
      Francisco, CA 94104

            

    

    

    

    
      	
               
      

            	
              If
      to AAQS, to:

            	
              American
      Antiquities, Inc.

            

    

    
      	
               
      

            	
              1085
      Cambridge Drive

            

    

    
      	
               
      

            	
              Buffalo
      Grove, Illinois  60089

            

    

    

    With
copies to (which shall not constitute notice):

    

    
      	
               
      

            	
              Bellevue
      Holdings, Inc.

            

    

    
      	
               
      

            	
              1085
      Cambridge Drive

            

    

    
      	
               
      

            	
              Buffalo
      Grove, Illinois  60089

            

    

     

    or such
other addresses as shall be furnished in writing by any party in the manner for
giving notices hereunder, and any such notice or communication shall be deemed
to have been given (i) upon receipt, if personally delivered, (ii) on the day
after dispatch, if sent by overnight courier, (iii) upon dispatch, if
transmitted by telecopy and receipt is confirmed by telephone and (iv) three (3)
days after mailing, if sent by registered or certified mail.

     

    
      
         

      

      
        18

        
          

        

      

      
         

      

    

    Section
8.04           Attorney’s
Fees.  In the
event that either party institutes any action or suit to enforce this Agreement
or to secure relief from any default hereunder or breach hereof, the prevailing
party shall be reimbursed by the losing party for all costs, including
reasonable attorney’s fees, incurred in connection therewith and in enforcing or
collecting any judgment rendered therein.

     

    Section
8.05           Confidentiality.  Each
party hereto agrees with the other that, unless and until the transactions
contemplated by this Agreement have been consummated, it and its representatives
will hold in strict confidence all data and information obtained with respect to
another party or any subsidiary thereof from any representative, officer,
director or employee, or from any books or records or from personal inspection,
of such other party, and shall not use such data or information or disclose the
same to others, except (i) to the extent such data or information is published,
is a matter of public knowledge, or is required by law to be published; or (ii)
to the extent that such data or information must be used or disclosed in order
to consummate the transactions contemplated by this Agreement.  In the
event of the termination of this Agreement, each party shall return to the other
party all documents and other materials obtained by it or on its behalf and
shall destroy all copies, digests, work papers, abstracts or other materials
relating thereto, and each party will continue to comply with the
confidentiality provisions set forth herein.

     

    Section
8.06           Public Announcements and
Filings.  Unless
required by applicable law or regulatory authority, none of the parties will
issue any report, statement or press release to the general public, to the
trade, to the general trade or trade press, or to any third party (other than
its advisors and representatives in connection with the transactions
contemplated hereby) or file any document, relating to this Agreement and the
transactions contemplated hereby, except as may be mutually agreed by the
parties.  Copies of any such filings, public announcements or
disclosures, including any announcements or disclosures mandated by law or
regulatory authorities, shall be delivered to each party at least one (1)
business day prior to the release thereof.

     

    Section
8.07           Schedules;
Knowledge.  Each
party is presumed to have full knowledge of all information set forth in the
other party’s schedules delivered pursuant to this Agreement.

     

    Section
8.08           Third Party
Beneficiaries.  This
contract is strictly between AAQS, the PAWS Shareholders and PAWS, and, except
as specifically provided, no director, officer, stockholder (other than the PAWS
Shareholders), employee, agent, independent contractor or any other person or
entity shall be deemed to be a third party beneficiary of this
Agreement.

     

    Section
8.09           Expenses.  Subject
to Article VI and VII above, whether or not the Exchange is consummated, each of
AAQS and PAWS will bear their own respective expenses, including legal,
accounting and professional fees, incurred in connection with the Exchange or
any of the other transactions contemplated hereby.

     

    Section
8.10           Entire
Agreement.  This
Agreement represents the entire agreement between the parties relating to the
subject matter thereof and supersedes all prior agreements, understandings and
negotiations, written or oral, with respect to such subject matter.

     

    Section
8.11           Survival;
Termination.  The
representations, warranties, and covenants of the respective parties shall
survive the Closing Date and the consummation of the transactions herein
contemplated for a period of one year.

     

    Section
8.12           Counterparts.  This
Agreement may be executed in multiple counterparts, each of which shall be
deemed an original and all of which taken together shall be but a single
instrument.

     

    
      
         

      

      
        19

        
          

        

      

      
         

      

    

    Section
8.13           Amendment or
Waiver.  Every
right and remedy provided herein shall be cumulative with every other right and
remedy, whether conferred herein, at law, or in equity, and may be enforced
concurrently herewith, and no waiver by any party of the performance of any
obligation by the other shall be construed as a waiver of the same or any other
default then, theretofore, or thereafter occurring or existing.  At
any time prior to the Closing Date, this Agreement may by amended by a writing
signed by all parties hereto, with respect to any of the terms contained herein,
and any term or condition of this Agreement may be waived or the time for
performance may be extended by a writing signed by the party or parties for
whose benefit the provision is intended.

     

    Section
8.14           Best
Efforts.  Subject
to the terms and conditions herein provided, each party shall use its best
efforts to perform or fulfill all conditions and obligations to be performed or
fulfilled by it under this Agreement so that the transactions contemplated
hereby shall be consummated as soon as practicable.  Each party also
agrees that it shall use its best efforts to take, or cause to be taken, all
actions and to do, or cause to be done, all things necessary, proper or
advisable under applicable laws and regulations to consummate and make effective
this Agreement and the transactions contemplated herein.

     

    

    [Signature
Pages Follow]

     

    
      
         

      

      
        20

        
          

        

      

      
         

      

    

    IN WITNESS WHEREOF, the
corporate parties hereto have caused this Agreement to be executed by their
respective officers, hereunto duly authorized, as of the date first-above
written.

     

    
      
        
          
            
              
                
                  
                    
                      
                        
                          
                            
                              
                                
                                  
                                    
                                      
                                        
                                          
                                            
                                              
                                                
                                                  
                                                    
                                                      
                                                        
                                                          
                                                            
                                                              
                                                                
                                                                  
                                                                    
                                                                      
                                                                        
                                                                          
                                                                            
                                                                              
                                                                                
                                                                                  
                                                                                    
                                                                                      
                                                                                        
                                                                                          
                                                                                            
                                                                                              
                                                                                                
                                                                                                  	 	
                                                                                                          “AAQS”:

                                                                                                        
	 	
                                                                                                          AMERICAN
      ANTIQUITIES, INC.

                                                                                                        
	 	 
      	 
      	 
      	 
	 	
                                                                                                          By:

                                                                                                        	    
      	 
	 	 
      	
                                                                                                          Name:
      

                                                                                                        	Joseph
      A. Merkel
	 	 
      	
                                                                                                          Title:   

                                                                                                        	Chief
      Executive Officer and Director
	 	 
      	 
      	 
      	 
	 	
                                                                                                          And

                                                                                                        
	 	 
      	 
      	 
      	 
	 	
                                                                                                          “BHI”:

                                                                                                        
	 	
                                                                                                          BELLEVUE
      HOLDINGS, INC.

                                                                                                        
	 	 
      	 
      	 
      	 
	 	 
      	 
      	 
      	 
	 	
                                                                                                          By:

                                                                                                        	
                                                                                                               
      

                                                                                                        	 
	 	 
      	
                                                                                                          Name:

                                                                                                        	 
      	 
	 	 
      	
                                                                                                          Title:

                                                                                                        	 
      	 
	 	 
      	 
      	 
      	 
	 	 
      	 
      	 
      	 
	 	 
      	 
      	 
      	 
	 	
                                                                                                              
      

                                                                                                        	 
	 	
                                                                                                          Joseph
      A. Merkel

                                                                                                        
	 	 
      	 
      	 
      	 
	 	 
      	 
      	 
      	 
	 	
                                                                                                               
      

                                                                                                        	 
	 	
                                                                                                          Kevin
      T. Quinlan

                                                                                                        
	 	 
      	 
      	 
      	 
	 	
                                                                                                          “PAWS”:

                                                                                                        
	 	
                                                                                                          PET
      AIRWAYS, INC.

                                                                                                        
	 	 
      	 
      	 
      	 
	 	 
      	 
      	 
      	 
	 	
                                                                                                          By:

                                                                                                        	
                                                                                                                 
      

                                                                                                        	 
	 	 
      	
                                                                                                          Name:
      

                                                                                                        	Daniel
      Wiesel
	 	 
      	
                                                                                                          Title:

                                                                                                        	 
      

                                                                                                

                                                                                              

                                                                                            

                                                                                          

                                                                                        

                                                                                      

                                                                                    

                                                                                  

                                                                                

                                                                              

                                                                            

                                                                          

                                                                        

                                                                      

                                                                    

                                                                  

                                                                

                                                              

                                                            

                                                          

                                                        

                                                      

                                                    

                                                  

                                                

                                              

                                            

                                          

                                        

                                      

                                    

                                  

                                

                              

                            

                          

                        

                      

                    

                  

                

              

            

          

        

      

    

    

    
      
         

      

      
        21

        
          

        

      

      
         

      

    

    Approved
and Accepted by the PAWS Shareholders:

     

    

    
      
        
          
            
              
                
                  
                    
                      
                        
                          
                            	 
      	 
      	 
      
	 
      	
                                    Name:
      Daniel
      Wiesel

                                  
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	
                                    Name: Alysa
      Binder

                                  
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	
                                    Name:
      Michele
      Hickford

                                  
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	
                                    Name:
      Pamela
      Kopelman

                                  

                          

                        

                      

                    

                  

                

              

            

          

        

      

    

     

    
      
         

      

      
        22

        
          

        

      

      
         

      

    

     

    
      
        
          
            	 
      	    
      
	 
      	
                    Daniel Wiesel, as
      Attorney-in-fact and Shareholder Representative on behalf of the
      following PAWS
shareholders:

                  

          

        

      

    

     

     

    
      
        	 
      	
                Dan
      and Alysa Wiesel

              
	 
      	
                John
      Dominguez (Shari)

              
	 
      	
                Ronald
      Blankstein

              
	 
      	
                Thomas
      Hooker

              
	 
      	
                OIG
      Global Private Equity Fund

              
	 
      	
                Charles
      Chiarelli (Cathy)

              
	 
      	
                Richard
      Johnson

              
	 
      	
                SPG
      Limited Partners

              
	 
      	
                Robert
      and Joyce Haberkorn

              
	 
      	
                Jean
      Muscarella Englert

              
	 
      	
                Kenneth
      Mishark (J. Crosby)

              
	 
      	
                (Diana
      Grubbs TTE)

              
	 
      	
                Hector
      Garcia (Lisa)

              
	 
      	
                Suburban
      Freight

              
	 
      	
                Recht
      Family Trust

              
	 
      	
                Zagorin
      (Trust)

              
	 
      	
                Susan
      and Irving Zagorin

              
	 
      	
                Alex
      Messing

              
	 
      	
                Alyze
      Tognotti

              
	 
      	
                Arden
      Moore

              
	 
      	
                Tracy
      Madera

              
	 
      	
                Kelly
      Bates

              
	 
      	
                Chris
      Stannish

              
	 
      	
                Terra
      Bruchert

              
	 
      	
                Michelle
      Dolan

              
	 
      	
                Steve
      Hansen

              
	 
      	
                Lindsey
      Newton

              
	 
      	
                Denise
      Rocks

              
	 
      	
                Janine
      Siatowski

              
	 
      	
                Blayne
      Smith

              
	 
      	
                Christina
      Smith

              
	 
      	
                Judy
      Taninies

              
	 
      	
                Carla
      Thomas

              
	 
      	
                Lindsay
      Thomas

              
	 
      	
                Quimbik

              
	 
      	
                Ben
      Edick

              
	 
      	
                Andrew
      Warner

              
	 
      	
                Dr
      Jeff Werber

              
	 
      	
                David
      Crane

              
	 
      	
                Areden
      Moore

              

      

    

     

    
      
         

      

      
        23

        
          

        

      

      
         

      

    

    Table
1:                      Exchange Shares to be
Issued

    

    
      
        
          
            
              
                
                  	
                          Name

                        	
                          Number of shares

                        
	
                          Dan
      and Alysa Wiesel

                        	 
      
	
                          Daniel
      Wiesel

                        	 
      
	
                          Alysa
      Binder

                        	 
      
	
                          Michele
      Hickford

                        	 
      
	
                          Pamela
      Kopelman

                        	 
      
	
                          John
      Dominguez (Shari)

                        	 
      
	
                          Ronald
      Blankstein

                        	 
      
	
                          Thomas
      Hooker

                        	 
      
	
                          OIG
      Global Private Equity Fund

                        	 
      
	
                          Charles
      Chiarelli (Cathy)

                        	 
      
	
                          Richard
      Johnson

                        	 
      
	
                          SPG
      Limited Partners

                        	 
      
	
                          Robert
      and Joyce Haberkorn

                        	 
      
	
                          Jean
      Muscarella Englert

                        	 
      
	
                          Kenneth
      Mishark (J. Crosby)

                        	 
      
	
                          (Diana
      Grubbs TTE)

                        	 
      
	
                          Hector
      Garcia (Lisa)

                        	 
      
	
                          Suburban
      Freight

                        	 
      
	
                          Recht
      Family Trust

                        	 
      
	
                          Zagorin
      (Trust)

                        	 
      
	
                          Susan
      and Irving Zagorin

                        	 
      
	
                          Alex
      Messing

                        	 
      
	
                          Alyze
      Tognotti

                        	 
      
	
                          Arden
      Moore

                        	 
      
	
                          Tracy
      Madera

                        	 
      
	
                          Kelly
      Bates

                        	 
      
	
                          Chris
      Stannish

                        	 
      
	
                          Terra
      Bruchert

                        	 
      
	
                          Michelle
      Dolan

                        	 
      
	
                          Steve
      Hansen

                        	 
      
	
                          Lindsey
      Newton

                        	 
      
	
                          Denise
      Rocks

                        	 
      
	
                          Janine
      Siatowski

                        	 
      
	
                          Blayne
      Smith

                        	 
      
	
                          Christina
      Smith

                        	 
      
	
                          Judy
      Taninies

                        	 
      
	
                          Carla
      Thomas

                        	 
      
	
                          Lindsay
      Thomas

                        	 
      
	
                          Quimbik

                        	 
      
	
                          Ben
      Edick

                        	 
      
	
                          Andrew
      Warner

                        	 
      
	
                          Dr
      Jeff Werber

                        	 
      
	
                          David
      Crane

                        	 
      
	
                          Areden
      Moore

                        	 
      
	 
      	 
      
	 
      	 
      
	 
      	 
      
	
                          Total

                        	
                          25,000,000

                        
	 
      	 
      

                

              

            

          

        

      

    

     

    
      
         

      

      
        24

        
          

        

      

      
         

      

    

    PET
AIRWAYS, INC.  (“PAWS”)

    Share
Exchange Agreement

    PAWS
Schedules

    June   ,
2010

    

    
      
        
          
            
              
                
                  
                    
                      
                        
                          
                            
                              
                                
                                  
                                    
                                      
                                        
                                          
                                            
                                              
                                                
                                                  
                                                    
                                                      	
                                                              Section
      1.03

                                                              Subsidiaries

                                                            	 
      
	 
      
	
                                                              Section
      1.04

                                                              Financial Statements

                                                            	 
      
	
                                                              Audited
      financial statements for the years ended December 31, 2008 and 2009 are
      attached.

                                                            
	 	 
	
                                                              Section
      1.06

                                                              Options and Warrants

                                                               PAWS
      14% convertible Debenture in principal amount of $250,000 issued on June
      18, 2010 (the “PAWS 14% Debenture”);

                                                              PAWS
      8% convertible Debenture in principal amount of $900,000 (the “PAWS 8%
      Debenture”)

                                                               

                                                            	 
      
	
                                                              Section
      1.07

                                                              Absence of Certain Changes or
      Events

                                                            	 
      
	 	 
	
                                                              None.

                                                            	 
      
	 	 
	
                                                              Section
      1.08

                                                              Litigation and Proceedings

                                                            	 
      
	
                                                              None.

                                                            
	 
	
                                                              Section
      1.09

                                                              Contracts

                                                            	 
      
	
                                                              None.

                                                            	 
      
	 	 
	
                                                              Section
      3.04

                                                              Finders

                                                            	 
      
	
                                                              PAWS
      has entered into a term sheet dated March 11, 2010 (the “Term Sheet”) with
      Alpine Capital Partners, Inc. (“Alpine”), which provided non-binding terms
      for the share exchange and private offering.  No fees are
      payable to Alpine under the Term Sheet; however the Term Sheet
      contemplates that a broker in the private offering may receive a fee of up
      to 10% from such transaction payable out of the proceeds of such
      transaction.

                                                            	 
      

                                                    

                                                  

                                                

                                              

                                            

                                          

                                        

                                      

                                    

                                  

                                

                              

                            

                          

                        

                      

                    

                  

                

              

            

          

        

      

    

     

    
      
         

      

      
        B-1

        
          

        

      

      
         

      

    

    

    AMERICAN
ANTIQUITIES, INC. (“AAQS”)

    Share
Exchange Agreement

    AAQS
Schedules

    June__,
2010

    

    
      
        
          
            
              
                
                  
                    
                      
                        
                          
                            
                              
                                	
                                        Section
      2.02

                                        Options and Warrants

                                      	 
      	 
      
	 	 	 
	
                                        Section
      2.03

                                        Subsidiaries

                                      
	 
	
                                        Section
      2.04

                                        Financial Statements

                                      	 
      	 
      
	
                                         

                                      	 
      	 
      
	
                                        Section
      2.07

                                        Absence of Certain Changes or
      Events

                                      	 
      	 
      
	
                                        [None.]

                                      	 
      	 
      
	 	 	 
	
                                        Section
      2.08

                                        Litigation and Proceedings

                                      	 
      	 
      
	
                                        [None.]

                                      	 
      
	 	 
	
                                        Section
      2.09

                                        Contracts

                                      	 
      	 
      
	
                                        Employment
      contract with Joseph A. Merkel dated June 6, 2009

                                        Employment
      contract with Kevin T. Quinlan dated June 6, 2009

                                      	 
      	 
      
	 	 	 
	
                                        Section
      2.19

                                        Real Estate

                                      	 
      	 
      

                              

                            

                          

                        

                      

                    

                  

                

              

            

          

        

      

    

     

    
      
         

      

      
        B-2Unassociated Document

    Exhibit
4.5

    

    ZIOPHARM
Oncology, Inc.

    

    Amendment
No. 4 to

    2003
Stock Option Plan

    

    

    This Amendment No. 4 to 2003 Stock
Option Plan (the “Amendment”) dated as of June
23, 2010, amends the 2003 Stock Option Plan (the “2003 Plan”) of ZIOPHARM Oncology,
Inc. (the “Company”).  Except
as otherwise explicitly set forth herein, all provisions of the 2003 Plan shall
remain in full force and effect.  Capitalized terms used in this
Amendment without definition shall have the meanings set forth in the 2003
Plan.

    

    WHEREAS, the 2003 Plan
provides that the number of shares of Common Stock which may be issued under the
Plan shall not exceed 6,002,436 shares; and

    

    WHEREAS,  an
amendment to the 2003 Plan increasing the number of shares of Common Stock which
may be issued under the Plan to 9,002,436 was adopted by the Company pursuant to
resolutions of the Board of Directors on March 31, 2010 and approved by the
Company’s stockholders at a meeting of the stockholders held on June 23,
2010.

    

    NOW, THEREFORE, the 2003 Plan
is hereby amended as follows:

    

    1.           Increase in Number of Shares Subject
to the Plan.  Section 5.1 of the 2003 Plan is hereby amended in
its entirety to read as follows:

    

    “5.1.           Number of Shares.
Subject to adjustment as provided in Section 10.6, the number of shares of
Common Stock which may be issued under the Plan shall not exceed 9,002,436
shares of Common Stock.  Shares of Common Stock that are issued under
the Plan or are subject to outstanding Incentives will be applied to reduce the
maximum number of shares of Common Stock remaining available for issuance under
the Plan.”

     

    2.           Effective Date. This Amendment
shall be effective upon the date first written above.

     

    

    IN WITNESS WHEREOF, the
Company has caused this Amendment to be executed by the undersigned officer,
thereunto duly authorized pursuant to the resolutions of the Board of
Directors.

     

    
      
        
          	 	
                  ZIOPHARM
      Oncology, Inc.:

                	 
	 	 	 	 
	
                   

                	
                  By:
      

                	/s/ Richard
      E. Bagley	 
	 	 	Richard
      E. Bagley,
      	 
	 	 	President,
      Chief Operating Officer, Chief Financial Officer and
    Secretary

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}]]